In the pharmaceutical industry, the quest for efficient drug delivery, enhanced solubility, and stabilization of active ingredients is constant. Wacker Chemie AG offers a cutting-edge solution with CAVAMAX® W6 PHARMA, a pharmaceutical-grade alpha-cyclodextrin.

Pycnogenol® is a distinguished nutraceutical ingredient derived from the bark of the French maritime pine tree (Pinus pinaster). Known for its exceptional antioxidant properties, Pycnogenol® is celebrated for its blend of active compounds, including procyanidins, bioflavonoids, and organic acids.

Texture plays a fundamental role in cosmetics formulations not only for product performance, but for user experience as well. The consistency of a product impacts not only how it applies to the skin or hair but also its stability, spread ability, and overall effectiveness.

DKSH has signed a strategic partnership agreement with Trautec, a leader in revolutionary recombinant human collagen technology for skincare and haircare, in Canada and the USA. By distributing Trautec’s ingredients for the personal care industry, DKSH will boost business opportunities for the partnership in Canada and the USA.

DKSH introduces its newly upgraded local digital customer portal “Discover” in China. The development of this digital platform enhances user experience and also focuses on providing a comprehensive showcase of products and case studies, offering clearer and richer content, more convenient navigation, and a more efficient interactive experience.

Blanose CMC, a sodium carboxymethylcellulose (CMC) from Ashland, is a reliable and multi-functional excipient designed to enhance the efficacy and stability of various pharmaceutical formulations.

The increasing demand for modified release dosage forms in the nutraceutical sector is being effectively addressed by Benecel™ Hydroxypropylmethylcellulose (HPMC), enhancing patient compliance through consistent release of active components.

We are excited to introduce our enhanced range of high-quality active pharmaceutical ingredients (APIs) through our collaboration with Refarmed Chemicals, now part of the DKSH Group.

The development of needle-free injection technology (NFIT) represents a significant advancement in diabetes management, providing a promising alternative to traditional needle-based insulin delivery methods.